Does tumor rupture during robot-assisted partial nephrectomy have an impact on mid-term tumor recurrences?

Hawlina, Simon; Cerovic, Kosta; Kondza, Andraz; Popovic, Peter; Bizjak, Jure; Smrkolj, Tomaz

doi:10.2478/raon-2023-0031

Abstract

Background

Intraoperative kidney tumor rupture (TR) can occur during robot-assisted partial nephrectomy (RAPN) in daily clinical practice, but there are no solid guidelines on the management and implications of it. The purpose of the study was to investigate the impact of TR on tumor recurrences, what a surgeon should do if this adverse event occurs, and how to avoid it.

Patients and methods

We retrospectively analyzed the first 100 patients who underwent RAPN at University Medical Centre Ljubljana, between 2018 and 2021. Patients were stratified into 2 groups (TR and no-TR) and were compared according to patient, tumor, pathologic, perioperative and postoperative characteristics and tumor recurrences, using the Mann-Whitney U test and chi-squared test.

Results

Of the 100 patients, 14 had TR (14%); this occurred in tumors with higher RENAL nephrometry scores (P = 0.028) and mostly with papillary renal cell carcinomas (P = 0.043). Median warm ischemia time was longer for the TR group (22 vs. 15 min, P = 0.026). In terms of studied outcomes, there were no cases of local or distant recurrence after a median observation time of 39 months (interquartile range, 31–47 months) in both groups. We observed positive surgical margins on the final oncologic report in one case in the no-TR group.

Conclusions

Tumor rupture during RAPN seems to be of no mid-term oncologic importance. According to presented results, we would recommend surgeons to proceed with tumor resection if this event occurs and abstain from conversion to radical nephrectomy or open partial nephrectomy. However, more similar cases should be studied to make more solid conclusions.

References

Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: the 2022 update. Eur Urol 2022; 82: 399–410. doi: 10.1016/J.EURURO.2022.03.006
Open DOI Search in Google Scholar Back to article
Minervini A, Campi R, Di Maida F, Mari A, Montagnani I, Tellini R, et al. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma. Urol Oncol 2018; 36: 527.e1–e11. doi: 10.1016/j.urolonc.2018.08.014
Open DOI Search in Google Scholar Back to article
Minervini A, Vittori G, Lapini A, Tuccio A, Siena G, Serni S, et al. Morbidity of tumour enucleation for renal cell carcinoma (RCC): results of a single-centre prospective study. BJU Int 2012; 109: 372–7. doi: 10.1111/J.1464-410X.2011.10360.X
Open DOI Search in Google Scholar Back to article
Minervini A, Serni S, Tuccio A, Raspollini MR, Di Cristofano C, Siena G, et al. Local recurrence after tumour enucleation for renal cell carcinoma with no ablation of the tumour bed: results of a prospective single-centre study. BJU Int 2011; 107: 1394–9. doi: 10.1111/J.1464-410X.2010.09949.X
Open DOI Search in Google Scholar Back to article
Khene ZE, Peyronnet B, Pradère B, Robert C, Goujon A, Kammerer-Jacquet SF, et al. Does tumour effraction during robotic partial nephrectomy have any impact on recurrence? Int J Clin Oncol 2019; 24: 87–93. doi: 10.1007/S10147-018-1331-2
Open DOI Search in Google Scholar Back to article
Pradere B, Peyronnet B, Delporte G, Manach Q, Khene ZE, Moulin M, et al. Intraoperative cyst rupture during partial nephrectomy for cystic renal masses – does it increase the risk of recurrence? J Urol 2018; 200: 1200–6. doi: 10.1016/j.juro.2018.06.025
Open DOI Search in Google Scholar Back to article
Chen SZ, Wu YP, Chen SH, Li XD, Sun XL, Huang JB, et al. Risk factors for intraoperative cyst rupture in partial nephrectomy for cystic renal masses. Asian J Surg 2021; 44: 80–6. doi: 10.1016/j.asjsur.2020.03.006
Open DOI Search in Google Scholar Back to article
Kwon EO, Carver BS, Snyder ME, Russo P. Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. BJU Int 2007; 99: 286–9. doi: 10.1111/j.1464-410X.2006.06623.x
Open DOI Search in Google Scholar Back to article
Cerović K, Hawlina S. How I do it: transabdominal robot-assisted laparoscopic partial nephrectomy. Surgery Surg Endos 2021; 3: 41–7.
Search in Google Scholar Back to article
Kutikov A, Uzzo RG. The R.E.N.A.L. Nephrometry Score: a comprehensive standardized system for quantitating renal tumor Size, location and depth. J Urol 2009; 182: 844–53. doi: 10.1016/j.juro.2009.05.035
Open DOI Search in Google Scholar Back to article
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13. doi: 10.1097/01.sla.0000133083.54934.ae
Open DOI Search in Google Scholar Back to article
Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, et al. Positive surgical margins increase risk of recurrence after partial nephrectomy for high risk renal tumors. J Urol 2016; 196: 327–34. doi: 10.1016/j.juro.2016.02.075
Open DOI Search in Google Scholar Back to article
Mouracade P, Kara O, Maurice MJ, Dagenais J, Malkoc E, Nelson RJ, et al. Patterns and predictors of recurrence after partial nephrectomy for kidney tumors. J Urol 2017; 197: 1403–9. doi: 10.1016/j.juro.2016.12.046
Open DOI Search in Google Scholar Back to article
Margonis GA, Kim Y, Prescott JD, Tran TB, Postlewait LM, Maithel SK, et al. Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes. Ann Surg Oncol 2016; 23: 134–41. doi: 10.1245/s10434-015-4803-x
Open DOI Search in Google Scholar Back to article
Hong X, Li T, Ling F, Yang D, Hou L, Li F, et al. Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis. Oncotarget 2017; 8: 17258–69. doi: 10.18632/oncotarget.12907
Open DOI Search in Google Scholar Back to article
Takagi T, Yoshida K, Wada A, Kondo T, Fukuda H, Ishihara H, et al. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution. Int J Clin Oncol 2020; 25: 892–8. doi: 10.1007/S10147-020-01632-X
Open DOI Search in Google Scholar Back to article
Grossmann NC, Mischo A, Rupp NJ, Hermanns T. Peritoneal carcinomatosis of a cystic papillary renal cell carcinoma following intraoperative cyst rupture during partial nephrectomy: a case report and review of the literature. Curr Probl Cancer: Case Rep 2022; 8: 100198. doi: 10.1016/j.cpccr.2022.100198
Open DOI Search in Google Scholar Back to article
Arai T, Sazuka T, Sato H, Kato M, Kamada S, Katsura S, et al. A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study. Int J Clin Oncol 2022; 27: 1467–76. doi: 10.1007/S10147-022-02204-X
Open DOI Search in Google Scholar Back to article
Fujii Y, Ikeda M, Kurosawa K, Tabata M, Kamigaito T, Hosoda C, et al. Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma. Int J Clin Oncol 2014; 20: 802–807. doi: 10.1007/S10147-014-0775-2
Open DOI Search in Google Scholar Back to article
Beauval JB, Peyronnet B, Benoit T, Cabarrou B, Seisen T, Roumiguié M, et al. Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study. World J Urol 2018; 36: 897–904. doi: 10.1007/s00345-018-2208-8
Open DOI Search in Google Scholar Back to article
Kara O, Akca O, Zargar H, Andrade HS, Maurice MJ, Ramirez D, et al. Robotic partial nephrectomy in the treatment of renal angiomyolipoma. J Endourol 2016; 30: 275–9. doi: 10.1089/end.2015.0624
Open DOI Search in Google Scholar Back to article
Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, et al. Outcomes of robot-assisted partial nephrectomy for clinical T2 renal tumors: a multicenter analysis (ROSULA Collaborative Group). Eur Urol 2018; 74: 226–32. doi: 10.1016/j.eururo.2018.05.004
Open DOI Search in Google Scholar Back to article
Hu JC, Treat E, Filson CP, McLaren I, Xiong S, Stepanian S, et al. Technique and outcomes of robot-assisted retroperitoneoscopic partial nephrectomy: a multicenter study. Eur Urol 2014; 66: 542–9. doi: 10.1016/j.eururo.2014.04.028
Open DOI Search in Google Scholar Back to article
Roquero L, Kryvenko ON, Gupta NS, Lee MW. Characterization of fibromuscular pseudocapsule in renal cell carcinoma. Int J Surg Pathol 2015; 23: 359–63. doi: 10.1177/1066896915579198
Open DOI Search in Google Scholar Back to article
Jacob JM, Williamson SR, Gondim DD, Leese JA, Terry C, Grignon DJ, et al. Characteristics of the peritumoral pseudocapsule vary predictably with histologic subtype of T1 renal neoplasms. Urology 2015; 86: 956–61. doi: 10.1016/J.UROLOGY.2015.06.015
Open DOI Search in Google Scholar Back to article
Hora M, Hes O, Klečka J, Boudová L, Chudáček Z, Kreuzberg B, et al. Rupture of papillary renal cell carcinoma. Scand J Urol Nephrol 2009; 38: 481–4. doi: 10.1080/00365590410018648
Open DOI Search in Google Scholar Back to article
Macklin PS, Sullivan ME, Tapping CR, Cranston DW, Webster GM, Roberts ISD, et al. Tumour seeding in the tract of percutaneous renal tumour biopsy: a report on seven cases from a UK tertiary referral centre. Eur Urol 2019; 75: 861–7. doi: 10.1016/J.EURURO.2018.12.011
Open DOI Search in Google Scholar Back to article
Piramide F, Kowalewski KF, Cacciamani G, Rivero Belenchon I, Taratkin M, Carbonara U, et al. Three-dimensional model-assisted minimally invasive partial nephrectomy: a systematic review with meta-analysis of comparative studies. Eur Urol Oncol 2022; 5: 640–50. doi: 10.1016/J.EUO.2022.09.003
Open DOI Search in Google Scholar Back to article